Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix

被引:66
作者
Takeda, M [1 ]
Sakuragi, N [1 ]
Okamoto, K [1 ]
Todo, Y [1 ]
Minobe, SI [1 ]
Nomura, E [1 ]
Negishi, H [1 ]
Oikawa, M [1 ]
Yamamoto, R [1 ]
Fujimoto, S [1 ]
机构
[1] Hokkaido Univ, Sch Med, Dept Obstet & Gynecol, Kita Ku, Sapporo, Hokkaido 0608638, Japan
关键词
cervical carcinoma; lymph node metastasis; SCC; CA125; CA19-9;
D O I
10.1034/j.1600-0412.2002.810513.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background. We wanted to investigate the clinical usefulness of determining the pretreatment levels of multiple serum tumor markers in predicting lymph node status and the prognosis for patients with cervical carcinoma. Methods. The preoperative serum levels of squamous cell carcinoma antigen (SCC), cancer antigens CA125 and CA19-9 were assayed simultaneously in 103 patients with stages IB to IIB cervical SCC undergoing radical hysterectomy. The cut-off values of SCC, CA125, and CA19-9 in this study were 1.5 ng/ml, 35 U/ml, and 37 U/ml, respectively. The relation between preoperative tumor marker levels and histopathologic prognostic factors including lymph node metastasis and patient survival was studied. Results. Preoperative serum SCC, CA125, and CA19-9 levels were significantly related to the FIGO stage. In addition, serum SCC and CA125 levels were significantly related to tumor diameter, depth of cervical stromal invasion, lymph-vascular space invasion, and lymph node metastasis. We subsequently created a double-tumor-marker (DTM) index, which incorporated the number of positive markers of SCC and CA125. The DTM index was strongly related to the number of positive pelvic lymph nodes (p=0.0002) and to the site of positive nodes (none vs. pelvic only vs. common iliac/paraaortic) (p=0.0005). Probability of lymph node metastasis according to the DTM index=0, 1, and 2 was 6/48 (12.5%), 14/45 (31.1%), and 8/10 (80.0%), respectively. The rate of common iliac/paraaortic node metastasis according to the DTM index=0, 1, and 2 was 1148 (2.1%), 2/45 (4.4%), and 3110 (30.0%), respectively. By logistic regression analysis, it was shown that the DTM index and tumor diameter were independently related to lymph node metastasis. Using multivariate Cox regression analysis including singly determined serum SCC and CA125 levels, clinical stage (IB/IIA vs. IIB), tumor diameter (less than or equal to2 vs. 2-4 vs. >4cm), parametrial invasion, lymph node metastasis, and the DTM index, the DTM index was found to be the most important prognostic factor (p=0.0005). However, when the sites of positive nodes were included in the multivariate analysis, only the sites of positive nodes (p=0.0008) and parametrial invasion (p=0.041) showed independent prognostic significance. Conclusion. Combination assay of pretreatment serum SCC and CA125 levels seems to be useful in estimating lymph node status and the prognosis for patients with cervical SCC in a preoperative setting.
引用
收藏
页码:451 / 457
页数:7
相关论文
共 18 条
[1]   PROGNOSTIC-SIGNIFICANCE OF PRETREATMENT SERUM LEVELS OF SQUAMOUS-CELL CARCINOMA ANTIGEN AND CA125 IN CERVICAL-CARCINOMA [J].
AVALLLUNDQVIST, EH ;
SJOVALL, K ;
NILSSON, BR ;
ENEROTH, PHE .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (10) :1695-1702
[2]   COMPARISON OF L-SELECTIN AND E-SELECTIN LIGAND SPECIFICITIES - THE L-SELECTIN CAN BIND THE E-SELECTIN LIGANDS SIALYL LEX AND SIALYL LEA [J].
BERG, EL ;
MAGNANI, J ;
WARNOCK, RA ;
ROBINSON, MK ;
BUTCHER, EC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (02) :1048-1055
[3]  
DUK JM, 1989, OBSTET GYNECOL, V73, P661
[4]   Pretreatment serum squamous cell carcinoma antigen: A newly identified prognostic factor in early-stage cervical carcinoma [J].
Duk, JM ;
Groenier, KH ;
deBruijn, HWA ;
Hollema, H ;
tenHoor, KA ;
vanderZee, AGJ ;
Aalders, JG .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) :111-118
[5]   Can initial serum Cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis? [J].
Gaarenstroom, KN ;
Kenter, GG ;
Bonfrer, JMG ;
Korse, CM ;
Van de Vijver, MJ ;
Fleuren, GJ ;
Trimbos, JB .
GYNECOLOGIC ONCOLOGY, 2000, 77 (01) :164-170
[6]   Ovarian cancer antigen CA 125 enhances the invasiveness of the endometriotic cell line EEC 145 [J].
Gaetje, R ;
Winnekendonk, DW ;
Scharl, A ;
Kaufmann, M .
JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 1999, 6 (05) :278-281
[7]   Impact of surgical staging in women with locally advanced cervical cancer [J].
Goff, BA ;
Muntz, HG ;
Paley, PJ ;
Tamimi, HK ;
Koh, WJ ;
Greer, BE .
GYNECOLOGIC ONCOLOGY, 1999, 74 (03) :436-442
[8]   The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy [J].
Hong, JH ;
Tsai, CS ;
Chang, JT ;
Wang, CC ;
Lai, CH ;
Lee, SP ;
Tseng, CJ ;
Chang, TC ;
Tang, SG .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (04) :823-830
[9]  
Kijima H, 2000, INT J ONCOL, V17, P55
[10]   The role of pretreatment squamous cell carcinoma antigen in predicting nodal metastasis in early stage cervical cancer [J].
Lin, H ;
ChangChien, CC ;
Huang, EY ;
Tseng, CW ;
Eng, HL ;
Huang, CC .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2000, 79 (02) :140-144